| PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia K Lima, JL Coelho-Silva, GS Kinker, DA Pereira-Martins, F Traina, ... Cancer Genetics 233, 56-66, 2019 | 18 | 2019 |
| Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia JC Lipreri da Silva, JL Coelho-Silva, K Lima, HP Vicari, M Lazarini, ... Cellular Oncology 44 (5), 1105-1117, 2021 | 17 | 2021 |
| Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms K Lima, JAEG Carlos, RM Alves-Paiva, HP Vicari, FP Souza Santos, ... Scientific reports 9 (1), 9895, 2019 | 15 | 2019 |
| The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy K Lima, DA Pereira-Martins, LBL de Miranda, JL Coelho-Silva, ... Blood cancer journal 12 (11), 151, 2022 | 11 | 2022 |
| STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells HP Vicari, JL Coelho-Silva, DA Pereira-Martins, AR Lucena-Araujo, ... Investigational New Drugs, 1-15, 2022 | 8 | 2022 |
| AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis JAEG Carlos, K Lima, LV Costa-Lotufo, A Leitão, JA Machado-Neto Investigational New Drugs 39, 1139-1149, 2021 | 8 | 2021 |
| Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours B dos Santos Passaia, K Lima, JL Kremer, BB da Conceição, ... Investigational New Drugs 38, 899-908, 2020 | 8 | 2020 |
| Differential profile of PIP4K2A expression in hematological malignancies K Lima, DM Ribeiro, P de Melo Campos, FF Costa, F Traina, STO Saad, ... Blood Cells, Molecules, and Diseases 55 (3), 228-235, 2015 | 8 | 2015 |
| Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP–FRB Interaction and Autophagy CA Parada, IP de Oliveira, MCF Gewehr, JA Machado-Neto, K Lima, ... Cells 11 (3), 385, 2022 | 7 | 2022 |
| Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia JAEG Carlos, K Lima, JL Coelho-Silva, R de Melo Alves-Paiva, ... Cellular Oncology 43, 1191-1201, 2020 | 7 | 2020 |
| NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells LBL de Miranda, K Lima, JL Coelho-Silva, F Traina, SS Kobayashi, ... Scientific Reports 12 (1), 17092, 2022 | 5 | 2022 |
| NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells JC Lipreri da Silva, MFL Carvalho, LBL de Miranda, BO de Almeida, ... Investigational New Drugs 40 (4), 728-737, 2022 | 5 | 2022 |
| Exploring redox vulnerabilities in JAK2V617F-positive cellular models K Lima, LR Lopes, JA Machado-Neto Hematology, Transfusion and Cell Therapy 43, 430-436, 2021 | 5 | 2021 |
| Synthetic cyclopenta [b] indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells HP Vicari, K Lima, R da Costa Gomes, DC Fernandes, JCL da Silva, ... European Journal of Pharmacology 894, 173853, 2021 | 5 | 2021 |
| Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax K Lima, HP Vicari, JAEG Carlos, JCL da Silva, LL Figueiredo-Pontes, ... Hematology, Transfusion and Cell Therapy 44, 124-127, 2022 | 4 | 2022 |
| Long-term effects of allogeneic hematopoietic stem cell transplantation on systemic inflammation in sickle cell disease patients JTC de Azevedo, TCM Costa, KC Lima, TT Maciel, PVB Palma, ... Frontiers in Immunology 12, 774442, 2021 | 4 | 2021 |
| Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms HP Vicari, K Lima, LV Costa-Lotufo, JA Machado-Neto Cancers 14 (24), 6080, 2022 | 2 | 2022 |
| Allogeneic haematopoietic stem cell transplantation resets T‐and B‐cell compartments in sickle cell disease patients LR Jarduli‐Maciel, JTC de Azevedo, E Clave, TCM Costa, LCM Arruda, ... Clinical & Translational Immunology 11 (4), e1389, 2022 | 2 | 2022 |
| Análise de padrões hematológicos como ferramenta preditiva para avaliar o risco de óbito em pacientes com Covid-19 AP Silva, AC Lira, MV Diniz, AVD Nascimento, WRC Silva, GR Aguiar, ... Hematology, Transfusion and Cell Therapy 43, S419, 2021 | 2 | 2021 |
| Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells CSM Reis-Silva, PC Branco, K Lima, FL Silva, PRH Moreno, V Guallar, ... Toxicology in Vitro 76, 105207, 2021 | 2 | 2021 |
